Pharmacy DIR Fee Relief at Last? What Retailers Should Know

Promoting and Advancing Petroleum Marketing, Retail Grocery, and Convenience Stores in West Virginia

Driving Local Business and Community Growth Across West Virginia

Our Purpose and Commitment

OMEGA is a West Virginia-based organization dedicated to supporting and advancing the business interests of the state’s petroleum marketing, retail grocery, and convenience store industries.

As a network of over 225 locally owned businesses, OMEGA actively promotes cooperation, advocates for favorable legislation, and provides education and resources to its members. With over 50,000 employees, OMEGA members significantly contribute to the state’s economy, generating more than 10% of all state taxes and supporting local communities through scholarships, charitable donations, and civic involvement.

OMEGA is committed to fostering industry growth while serving West Virginians with essential services like fuel, food, and convenience.

who frontpage

member frontpage

Join a Community that Champions, Connects, and Elevates!

Your Essential Connection in West Virginia

OMEGA offers three types of membership: Convenience Store Members, Petroleum Marketer Members, and Grocer Members, all of which play a vital role in providing fuel, food, and essentials across West Virginia. As a liaison with state and national agencies, OMEGA works closely with organizations like NACS, PMAA, FMI, and the N.G.A. to advocate on behalf of its members.

We keep members informed through newsletters, legislative updates, an online resource hub, and educational seminars. Additional member benefits include access to the Encova Workers’ Compensation Discount Program and participation in our annual Trade Expo and fundraising efforts for children’s charities. OMEGA is here to support, advocate, and enhance the success of our industry members.

The plan advocates for increased transparency throughout the pharmaceutical supply chain, including reforms that would upend the pharmacy benefit manager (PBM) business model, making it harder for PBMs to siphon money away from pharmacies via DIR fees.

By: Peter Matz, Director, Nutrition & Food Policy, Food Marketing Institute <img src="https://www.fmi.org/images/default-source/photos-for-staff-use/pharmacy/fmi-12092014_443-edit_web.tmb-large-350-.jpg?sfvrsn=de09a6f_2" data-displaymode="Thumbnail" alt="FMI-12092014_443-Edit_WEB" title="FMI-12092014_443-Edit_WEB" style="float: right; margin-bottom: 10px; margin-left: 10px;" />In May 2018, the Trump Administration released <a href="https://www.hhs.gov/sites/default/files/AmericanPatientsFirst.pdf">American Patients First</a>, a comprehensive blueprint to reduce prescription drug prices and out-of-pocket costs at the pharmacy counter. The plan advocates for increased transparency throughout the pharmaceutical supply chain, including reforms that would upend the pharmacy benefit manager (PBM) business model, making it harder for PBMs to siphon money away from pharmacies via DIR fees. To that end, the Department of Health & Human Services (HHS) recently released a <a href="https://www.regulations.gov/contentStreamer?documentId=CMS-2018-0149-0002&contentType=pdf">proposed rule</a> containing a number of positive policy reforms to pharmacy DIR fees. Most importantly, it would require all pharmacy fees to be included at the point of sale of the initial transaction, which would effectively eliminate the retroactive nature of pharmacy DIR fees. Food Marketing Institute (FMI) strongly supports the proposal, and thanks the Administration for this first, but important, step. Health and well-being, including pharmacy-specific programs, is of the utmost importance to our industry. Moreover, supermarket pharmacies provide a positive competitive market force in delivering affordable and accessible prescription medicines to consumers and patients. Over the years, however, FMI members have been frustrated by DIR fees, which PBMs have used strategically to recoup funds from pharmacies retroactively, often weeks or even months after prescriptions were filled. These retroactive fees, also commonly referred to as rebates or price concessions, are bad for consumer wallets and pharmacies alike: beneficiaries face higher cost-sharing for drugs, while the reimbursement uncertainty makes it extremely difficult for pharmacies to operate and take care of their patients (e.g. pharmacies often realize long after a prescription is filled that they didn’t even recoup their costs). According to the federal government, pharmacy DIR fees have grown by more than 45,000 percent between 2010 and 2017! And, in an industry that operates on razor thin profit margins, supermarket pharmacies have virtually no ability to absorb these unexpected costs. Therefore, they are forced to either pass those costs on to consumers in the form of higher prices, or worse, discontinue offering pharmacy services altogether at certain locations.  In January, we submitted <a href="https://fmi.us7.list-manage.com/track/click?u=03b48dc865603bf84c48b205e&id=9dc244d404&e=6b7dfbcf64">comments</a> in response to the aforementioned proposed rule. We expressed support for the proposal – especially the elimination of retroactive pharmacy DIR fees – and respectfully requested the Administration move forward in a timely manner. However, given the significance of this topic to FMI pharmacy members, we also included several cautionary points for consideration, such as the need for increased oversight of pharmaceutical supply chain intermediaries – particularly PBMs. To that end, we requested that HHS adopt requirements for PBMs to offer pharmacies reasonable and appropriate reimbursement terms for prescription drugs, which at a minimum, cover the cost of procuring drugs and providing other services related to their dispensing.  Additionally, we asked the Administration to develop and formalize a standard set of performance metrics with achievable goals tailored to pharmacy type, drug dispensed, and disease state being managed, from which all plans and pharmacies would base their contractual agreements. As written, the proposed rule demonstrates the Administration’s dedication to providing savings for consumers at the pharmacy counter, as well as needed support to pharmacies and their patients.  However, time will tell if/how the rule is finalized, and we will continue advocating for FMI pharmacies in the meantime. <a href="https://www.fmi.org/blog/view/webinar-recordings-member-only/2018/12/19/dir-fees-and-proposed-medicare-part-d-rule">Learn more about DIR Fees and the HHS proposed rule via our recent webinar.</a>

Read full article on FMI

Menus

Some of the main menus of the template are now set via the template parameters saving you having to set up menu modules for each menu. From this section you can choose what menus you would like connected with these pre assigned menu areas of the template.

Copyright Information

Enter the copyright information that will appear in the footer area of your template.

Supporting West Virginia Communities

OMEGA members play a vital role in West Virginia, supporting communities through substantial tax contributions and a wide-reaching presence across the state. With over 55% of the population living in border counties, our members are dedicated to serving both local and regional needs. Beyond business, we’re proud to give back, having contributed over $3.1 million to children’s charities since 2003, reflecting our commitment to making a positive difference.